4//SEC Filing
Pasternak Andy 4
Accession 0001209191-23-003733
CIK 0001492426other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:19 PM ET
Size
5.6 KB
Accession
0001209191-23-003733
Insider Transaction Report
Form 4
Pasternak Andy
EVP and Chief Business Officer
Transactions
- Sale
Ordinary Shares
2023-01-17$113.03/sh−27,129$3,066,323→ 56,338 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2022.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.0750 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001792746
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 4:19 PM ET
- Size
- 5.6 KB